These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12966886)

  • 21. [The photometric determination of the antilysozyme activity of microorganisms].
    Bukharin OV; Valyshev AV; Elagina NN; Ivanov IuB; Cherkasov SV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (4):117-20. PubMed ID: 9340990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of antilysozyme activity of Staphylococcus aureus in various types of experimental infection course].
    Bukharin OV; Usviatsov BIa; Sheenkov NV
    Biull Eksp Biol Med; 1993 Feb; 115(2):178-80. PubMed ID: 8043801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterobacteria modulate intestinal bile acid transport and homeostasis through apical sodium-dependent bile acid transporter (SLC10A2) expression.
    Miyata M; Yamakawa H; Hamatsu M; Kuribayashi H; Takamatsu Y; Yamazoe Y
    J Pharmacol Exp Ther; 2011 Jan; 336(1):188-96. PubMed ID: 20884752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro assessment of the gastrointestinal transit tolerance of taxonomic reference strains from human origin and probiotic product isolates of Bifidobacterium.
    Masco L; Crockaert C; Van Hoorde K; Swings J; Huys G
    J Dairy Sci; 2007 Aug; 90(8):3572-8. PubMed ID: 17638965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of bile salts on the DNA and membrane integrity of enteric bacteria.
    Merritt ME; Donaldson JR
    J Med Microbiol; 2009 Dec; 58(Pt 12):1533-1541. PubMed ID: 19762477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implications.
    Kundu S; Kumar S; Bajaj A
    IUBMB Life; 2015 Jul; 67(7):514-23. PubMed ID: 26177921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Microbial inhibitors of lysozyme].
    Bukharin OV; Valyshev AV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):8-13. PubMed ID: 16941860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lysozyme-antilysozyme interactions in protozoa-bacteria communities (a model Tetrahymena-Escherichia community)].
    Bukharin OV; Nemtseva NV
    Mikrobiologiia; 2001; 70(5):656-61. PubMed ID: 11763786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations.
    Domínguez-Muñoz JE; Birckelbach U; Glasbrenner B; Sauerbruch T; Malfertheiner P
    Aliment Pharmacol Ther; 1997 Apr; 11(2):403-8. PubMed ID: 9146782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Features of etiologic structure and factors of persistence of bacteria isolated during infection of lower urinary tract and chronic bacterial prostatitis].
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):8-12. PubMed ID: 23163027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of the antilysozyme activity of Shigella flexneri as a factor controlling the degree of its resistance to the lytic action of bacteriophages].
    Bukharin OV; Deriabin DG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):16-9. PubMed ID: 2694689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of bacterial population structure on anti-lysozyme activity under the influence of hexylresorcinol].
    Bukharin OV; Perunova NB; Iavnova SV
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):7-10. PubMed ID: 19189462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the mechanisms of pulsed electric fields on inactivation of enzyme: lysozyme.
    Zhao W; Yang R; Lu R; Tang Y; Zhang W
    J Agric Food Chem; 2007 Nov; 55(24):9850-8. PubMed ID: 17956144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The antilysozyme activity of meningococci].
    Bukharin OV; Borisov SD; Ezepchuk IuV; Kostiukova NN; Usviatsov BIa; Fan'kovskaia EK
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):17-20. PubMed ID: 1950256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The interaction of Escherichia coli, possessing the antilysozyme trait, with infusoria].
    Nemtseva NV
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (4):123-6. PubMed ID: 9340992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical evaluation of a pepsin-pancreatin-bile salt preparation.
    KAMMANDEL H; MCGAVACK TH; KLOTZ SD; BOYD LJ
    Bulletin NY Med Coll; 1951; 14():96-111. PubMed ID: 12997957
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of a polyoxydonium immunoregulator on the biological properties of microorganisms].
    Kirillov DA; Chaĭnikova IN; Perunova NB; Chelpachenko OE; Pan'kov AS; Smoliagin AI; Valyshev AV
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):74-8. PubMed ID: 12966885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of enterobacteria and Listeria growth by lactic, acetic and formic acids.
    Ostling CE; Lindgren SE
    J Appl Bacteriol; 1993 Jul; 75(1):18-24. PubMed ID: 8365950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A modification to the method for determining the antilysozyme activity of meningococcal strains].
    Belozerskiĭ VI
    Mikrobiol Z; 1999; 61(3):57-62. PubMed ID: 10483233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lysozyme in the material and the digestive secretions of the domestic rabbit].
    Bonnafous R; Raynaud P
    Reprod Nutr Dev (1980); 1980; 20(4B):1273-8. PubMed ID: 7349480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.